Clincosm LogoSign in Get a demo

minimal residual disease

Showing 26 - 45 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Lymphoblastic Leukemia, in Relapse, Chemotherapeutic Toxicity, Minimal Residual Disease Trial in Mexico City (Bortezomib)

Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +2 more
  • Mexico City, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
Jan 2, 2022

Chronic Lymphocytic Leukemia, Minimal Residual Disease Trial in Bath (Exercise trial)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • Minimal Residual Disease
  • Exercise trial
  • Bath, Bath & Northeast Somerset, United Kingdom
  • +1 more
Oct 20, 2021

Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Charlotte, Seattle (Clofarabine,

Terminated
Has Results
  • Minimal Residual Disease
  • +2 more
  • Charlotte, North Carolina
  • +1 more
Oct 4, 2021

Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Allogeneic Bone Marrow Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 13, 2021

ALL, Childhood, Minimal Residual Disease Trial in Worldwide (Blinatumomab)

Recruiting
  • ALL, Childhood
  • Minimal Residual Disease
  • Vienna, Austria(AUT), Austria
  • +14 more
Mar 4, 2021

Method to Search Residual Disease in Auto-cryopreserved Ovarian

Completed
  • Neoplastic Pathology
  • +2 more
    • Besançon, France
      CHRU Besancon
    Jan 26, 2021

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

    Terminated
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 1, 2020

    B Acute Lymphoblastic Leukemia, Minimal Residual Disease, Recurrent Acute Lymphoblastic Leukemia Trial in Seattle (Laboratory

    Terminated
    Has Results
    • B Acute Lymphoblastic Leukemia
    • +3 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2020

    Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Beijing (donor lymphocyte

    Unknown status
    • Donor Lymphocyte Infusion
    • +5 more
    • donor lymphocyte infusion
    • Beijing, Beijing, China
      Peking University Institute of Hematology,Beijing
    Mar 9, 2020

    Acute Myeloid Leukemia, Minimal Residual Disease Trial in Guangzhou (MRD-directed therapy)

    Completed
    • Acute Myeloid Leukemia
    • Minimal Residual Disease
    • MRD-directed therapy
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Mar 2, 2020

    Minimal Residual Disease, Donor Lymphocyte Infusion, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (donor

    Completed
    • Minimal Residual Disease
    • +3 more
    • donor lymphocyte infusion
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Feb 24, 2020

    Multiple Myeloma, Minimal Residual Disease, High-Risk Cancer Trial in New York (WT1 Analog Peptide Vaccine, Sargramostim

    Unknown status
    • Multiple Myeloma
    • +2 more
    • WT1 Analog Peptide Vaccine
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 6, 2020

    Colon Cancer, Minimal Residual Disease Trial in Brno, Zlin (Epidural analgesia, Piritramide, Morphine)

    Completed
    • Colon Cancer
    • Minimal Residual Disease
    • Epidural analgesia
    • +2 more
    • Brno, Jihomoravsky Kraj, Czechia
    • +1 more
    Mar 11, 2019

    Acute Myeloid Leukemia (AML), Minimal Residual Disease Trial in New York (Azacitidine, Avelumab)

    Withdrawn
    • Acute Myeloid Leukemia (AML)
    • Minimal Residual Disease
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 18, 2019

    Granulocyte Colony-stimulating Factor, Minimal Residual Disease, Acute Myeloid Leukemia Trial in Guangzhou (G-SCF)

    Unknown status
    • Granulocyte Colony-stimulating Factor
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 5, 2018

    Minimal Residual Disease in Acute Myeloid Leukemia

    Completed
    • Acute Myeloid Leukemia
    • +2 more
      • (no location specified)
      Mar 22, 2016

      Contamination of Ovarian Tissue by RT-PCR in Solid Tumors

      Unknown status
      • Minimal Residual Disease
      • Fertility Preservation
      • malignant cells
      • Clermont-Ferrand, France
        CHU de Clermont-Ferrand
      Mar 26, 2015

      Contamination of Testicle Tissue by RT-PCR in Solid Tumors

      Unknown status
      • Minimal Residual Disease
      • Fertility Preservation
      • malignant cells
      • Clermont-Ferrand, France
        CHU Clermont-Ferrand
      Mar 26, 2015

      Chronic Myeloid Leukemia, Minimal Residual Disease Trial in Houston (Synthetic Tumor-Specific Breakpoint Peptide Vaccine)

      Completed
      Has Results
      • Chronic Myeloid Leukemia
      • Minimal Residual Disease
      • Synthetic Tumor-Specific Breakpoint Peptide Vaccine
      • Houston, Texas
        UT MD Anderson Cancer Center
      Aug 1, 2012